Patent details

EP2203462 Title: NUCLEOSIDE PHOSPHORAMIDATE PRODRUGS

Basic Information

Publication number:
EP2203462
PCT Application Number:
US2008058183
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP087328183
PCT Publication Number:
WO2008121634
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NUCLEOSIDE PHOSPHORAMIDATE PRODRUGS
French Title of Invention:
PROMÉDICAMENTS DE PHOSPHORAMIDATE DE NUCLÉOSIDE
German Title of Invention:
NUKLEOSID-PHOSPHORAMIDAT-PRODRUGS
SPC Number:
92600

Dates

Filing date:
26/03/2008
Grant date:
21/05/2014
EP Publication Date:
07/07/2010
PCT Publication Date:
09/10/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/07/2010
EP B1 Publication Date:
21/05/2014
EP B2 Publication Date:
25/09/2024
EP B3 Publication Date:
Lapsed date:
Expiration date:
26/03/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/09/2024
 
 

Name:
Gilead Pharmasset LLC
Address:
Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, CA 94404, United States (US)

Agent

Name:
MARKS & CLERK LLP
From:
08/07/2014
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
SOFIA, Michael, Joseph
Address:
United States (US)

2

Name:
DU, Jinfa
Address:
United States (US)

3

Name:
NAGARATHNAM, Dhanapalan
Address:
United States (US)

4

Name:
WANG, Peiyuan
Address:
United States (US)

Priority

1

Priority Number:
909315 P
Priority Date:
30/03/2007
Priority Country:
United States (US)

2

Priority Number:
982309 P
Priority Date:
24/10/2007
Priority Country:
United States (US)

3

Priority Number:
53015
Priority Date:
21/03/2008
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/7064; A61K 31/7076;

Publication

European Patent Bulletin

Issue number:
202439
Publication date:
25/09/2024
Description:
Patent maintained (B2 publication)

Annual Fees

Annual Fee Due Date:
31/03/2026
Annual Fee Number:
19
Annual Fee Amount:
281 Euro
Expected Payer:
Last Annual Fee Payment Date:
13/03/2025
Last Annual Fee Paid Number:
18
Last Annual Fee Paid Amount:
262 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56